In Kenya, Novo Nordisk tests a new business model to
improve access to insulin (13 April 2012)
As part of an official Danish state visit to Kenya, Novo
Nordisk on 12 April officially launched a programme to make
insulin and diabetes care more accessible to poor
In Kenya, 250,000 people are in need of insulin out of
which 80,000 are people with an annual income between
1,500-3,000 US dollars. To make insulin more affordable and
accessible to this group, Novo Nordisk has in partnership
with local organisations and faith-based hospitals and
clinics developed a new business model that includes a
streamlined supply chain and treatment centres that are
closer to the patients' homes.
The project has reduced price mark-ups in the supply chain
to the extent that the insulin can be obtained at 20 cents
daily, which is equivalent to a third of the previous price
on the private market.
The Kenyan project is the first of three pilots to be
launched by Novo Nordisk this year. A second one is about
to be launched in India, and a third pilot will be launched
in Nigeria later in 2012.
The pilot projects will create valuable learnings on how
access to insulin and proper diabetes care can be improved
for people with diabetes with very low incomes.
Worldwide, there is a population of 46 million people with
diabetes who earn between 4 and 10 dollars per day. In
2030, this group is expected to grow to more than 73
Diabetes in Africa
According to the International Diabetes Federation, the
growth of diabetes in Africa is currently the highest in
the world. Close to 15 million people in sub-Saharan Africa
currently have diabetes, and this number is expected to
rise to around 28 million in 2030. It is estimated that 78%
of people with diabetes today are undiagnosed.
In Kenya, the International Diabetes Federation estimates
that there are currently around one million people with
diabetes in Kenya with urban prevalence up to 10%.
Video from Kenya will be available here Monday.